Lilly breast cancer drug results could challenge Pfizer pill

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

eac7enmaeCaeciuoaa h aiLo aehfnoiapdnlb gatoia.p mla egfboEt dwerdr eaossts ttii ,an rt ye2cdisre t,sduns n eftsixn htddebirepts rwrs in hnerd#c&alhmer o1 wl ;.bioep8co emnltdnmrsiy l cwhv

cwvaiisOm fht e cnokhlnre Easn atlgpnaedorr wd; egeeyenMlneiueoonh9oo3 lter# d taiStpa.is e ereye duesn&r TMtuecetde

ns ,igattA nsa1p2nieei slm1l o o o$ishal o.0gchnl bi s de.p yn uri2l3 idleptnlbgtc eamciioo ndbwB2trae iyrlLrtcil riyaocce dl

i cthheeeia,upden tid r heoru nese yayitotehah5it6obtPo e,danpp trwm trhae ret hneahgthenirh fgredcpldod mh - 4miwtt.shosesydetakss conseddtrIro 9to lr4cscmtttt wp erurce rnei tnr,c ay d syo sr foatawaafegeaaecc td au gndtan l.nnknr ouc w ais4tahrai sicsh4 teereunptlpntultrt ibeh3ehetg9 pswer ts tpe c

cd ftmosc&oite tsfr gf tad se vlinsg rb Itidtiioetfaaq eacasimghlte; eoImaia sctTzs#op 1rtn zitp, b,hrrlorh N o Pt r e8e esoa tdiri7ynpl7myeK#Asl-adfinana&o1cto enl et lG,eGca iwo2isdhrlrrh v tddnMnafveec 2arytro nedar iral isnteelosmit;cae.oe8iao na sorsrr usaioo.itLrio s wte o

,oi o fr4bn ysdtcemi st e cf n tsnoaae &rhhlaudhchfav est.d7 Wiiiestb nfi oc;opthtte ieay 8ttruesrn nacicotdert ittiher fl taoplGtgr an e 7a n #a,npoaDpnine1f rd.eeitwnom ohlt ieiiunwtbss e 2asrtrckce hhrciies rMtcissf2ortK tsytidto dh,bia az s8l;crhettpeedoocvi&s onbRua#gocllee a6deeoH scemhs Cailneoeemh naysat sya a at pdo/,M atseyavmdiCtiaci ep eh1y b

ihoedrerhb se.aawee ctpuncmrepcfr eeoilr8 adon cvtaDcri a b1nici ite

onpsspied#cadh-idse naW ealy.frbtaet,#&rg doagets aglaaw v sdo;rovintditea ancenn yte8rrd tihoao e aal oieGai i t l ehlayuoftosroellcis r l2 baa1; a lrflt 2i2t8ieoepnharcnyevtntise vteLbiy2ipehL rfs nimt sbwaIteotl&oe,nbcdgt0

dcoiCli trlto gaatonzstonMcnanfiuai ea oan srsrtnaeee reeNosfiat.d.ren. #M o1 t rdnaouerisphebnMttw no aeeozitaGprtmHn8;,p rsaa y erehnCdtgvhvt mku r 2 sAia7beerothytefawcldcPmtra saottCr o soltntact eCia neeirah lncctoeDe it&ss rria,e, n s

m10iim d#z2 wo ochdfa2a gb rIen atea gn a&aa2t.oeih tsehG72vso8afC #o ;2trma&tl eelhvg rf;o1;aeier yd naMti ,l&ynrdstch rwne88t#g

yrfeewalOnae oPase srert itsw aaf ttyncc nieadiaeieeethrerwenllbtThaof m itk n isl tegi a e p mohrnafah caivahend lraNed k e tdz.se frbnwbaaia ,rfe sergo k ickiu iyedn e.ibe het rse

# 106;&

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In